関連する実験動画
Updated: Jun 23, 2026

07:35
Gene Transfer for Ischemic Heart Failure in a Preclinical Model
Published on: May 15, 2011
心筋にウイルスが持続することは,進行的な心臓機能不全と関連しています
Uwe Kühl1, Matthias Pauschinger, Bettina Seeberg
1Charite, Universitätsmedizin Berlin, Campus Benjamin-Franklin, Medizinische Klinik II, Abteilung für Kardiologie und Pneumologie, Hindenburgdamm 30, 12200 Berlin, Germany. uwe.kuehl@charite.de
Circulation
|September 21, 2005
まとめ
エントロウイルスやパルボウイルスB19などのウイルス性心臓感染症は,心筋炎を引き起こす可能性があります. 自発的なウイルスのクリアランスは心臓機能を改善し,持続性はその状態を悪化させ,ウイルス性心筋病変の進行に関する洞察を提供します.
科学分野:
- 心臓病学 心臓病学
- ウイルス学 ウイルス学 ウイルス学
- 病理学 パトロジー
背景:
- 心臓型ウイルス感染症は,心筋炎と拡張性心筋症候群に関連しています.
- ウイルス性心臓病の自然な進行は,ほとんど不明のままです.
- 以前の研究では,拡張性心筋病症患者の不良結果が示唆されています.
研究 の 目的:
- ウイルス性心疾患の自然な経過を,心内組織生検を用いて調べる.
- ウイルスのクリアランスまたは持続が左心室機能に与える影響を決定する.
- 心筋組織における特定の心臓型ウイルスのクリアランス率を分析する.
主な方法:
- バイオプシーで証明されたウイルス感染症の172人の患者さんを内心筋バイオプシー (EMB) による分析.
- EMBと血液動力学的測定の再分析は,平均6.8ヶ月の追跡期間を経て行われました.
- ネストされたポリメラーゼ連鎖反応 (PCR) と逆転写-PCRを用いたウイルスゲノム配列の検出.
主要な成果:
- エントロウイルス (EV),アデノウイルス (ADV),パルボウイルスB19 (PVB19),ヒトヘルペスウイルス6 (HHV6) がEMBで検出されました.
- 単発感染の患者の36.2%で自発的なウイルスゲノムクリアランスが発生しました.
- ウイルスのクリアランスは左心室エジェクション分数 (LVEF) の改善と相関し,持続性はLVEFの低下につながった.
結論:
- この研究は,ウイルス性心臓病の進行に関する生検ベースの最初の分析を提供します.
- 心筋内でのウイルスの持続は,進行的なLVEF障害と関連しています.
- 自発的なウイルスの除去は,LV機能の重要な回復と関連しています.
関連する概念動画
Myocarditis I: Introduction
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...

